The advent of small-molecule targeted therapies, a decade ago, revolutionized the treatment of metastatic melanoma, provided that the tumors carry the mutations to respond to these treatments. However, despite a remarkable ...
Sep 22, 2022
0
31
Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast cancer cells regulate their own metastases, fuel dissemination from the original tumor site, and determine routes to invade distant ...
Sep 20, 2022
0
8
I am 48 and am being treated for metastatic breast cancer. Despite my diagnosis, I live a fairly normal life, am physically active and strive to optimize my health from a noncancer standpoint. An acquaintance who works in ...
Sep 19, 2022
0
9
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...
Sep 19, 2022
0
8
In the fall of 2018, cancer researcher Corrie Painter began presenting some intriguing early results from a new study on a rare and deadly cancer known as angiosarcoma. She and her fellow scientists hoped that by sharing ...
Sep 14, 2022
0
8
Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs and improve the value of care while preserving quality of life, according to a study led by ...
Sep 13, 2022
0
6
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in ...
Sep 12, 2022
0
6
Patients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer reported that the treatment maintained their quality of life (QoL) compared to conventional ...
Sep 12, 2022
0
9
Despite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researchers and oncologists.
Sep 6, 2022
0
40
Despite having lived with five different cancers over the last two decades—prostate, thyroid, kidney, appendix, and skin—Joel Nowak doesn't consider himself a "survivor." Rather, as a self-described "cancer thriver," ...
Aug 22, 2022
0
7
